title: Successful treatment of Langerhans'-cell histiocytosis with etanercept.
authors.forename: J I
authors.initials: JI
authors.lastname: Henter
authors.forename: J
authors.initials: J
authors.lastname: Karlén
authors.forename: U
authors.initials: U
authors.lastname: Calming
authors.forename: C
authors.initials: C
authors.lastname: Bernstrand
authors.forename: U
authors.initials: U
authors.lastname: Andersson
authors.forename: B
authors.initials: B
authors.lastname: Fadeel
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D000068800:Etanercept; D005260:Female; D006646:Histiocytosis, Langerhans-Cell / Q000188:drug therapy*; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use*; D013256:Steroids; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D007074:Immunoglobulin G; D007166:Immunosuppressive Agents; D018124:Receptors, Tumor Necrosis Factor; D013256:Steroids; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept